English | Español

Amgen Inc.
+ Technology/Innovation
Jamie Barrand | Feb 24, 2016

Romosozumab decreases spinal fracture risk in postmenopausal women, study indicates
+ Technology/Innovation
Jamie Barrand | Feb 18, 2016

Anemia therapy study yields positive results
+ Technology/Innovation
Jamie Barrand | Feb 9, 2016

Third trial of Repatha reveals positive results
+ Technology/Innovation
Matt Smith | Jan 26, 2016

FDA to review application for Amgen's ABP 501 treatment
+ Technology/Innovation
Jamie Barrand | Dec 27, 2015

Researchers unveil findings of acute lymphoblastic leukemia therapy trials
+ Technology/Innovation
Jamie Barrand | Dec 18, 2015

Amgen reacquires rights to three GSK medications
+ Technology/Innovation
Jamie Barrand | Dec 5, 2015

Amgen submits Marketing Authorization Application for ABP 501 to European Medicines Agency
+ Technology/Innovation
Jamie Barrand | Oct 16, 2015

Amgen, Allergan launch Phase 3 study of biosimilar candidate ABP 215

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes